Department of Psychiatry
Penn Behavioral Health
As part of the nation's first school of medicine, established in 1765, the Department of Psychiatry at Penn has a rich history, extending back over two centuries. The Department of Psychiatry is consistently ranked among the nationís top five psychiatry departments in its level of funding from the National Institutes of Health. Penn Behavioral Health offers an exceptionally strong and well-balanced program of clinical services, crossing all age groups and subspecialty areas of psychiatry and behavioral health.In addition to training future leaders in psychiatry, the department faculty are committed to educating the public and other health professionals about psychiatric disorders and treatment.

About the Department of Psychiatry at Penn

The Department of Psychiatry at the University of Pennsylvania is committed to the tripartite mission of providing the highest level of care to patients, conducting innovative research, and educating the future leaders in the field.

more about the Department of Psychiatry

Patient Care

Patient Care

view more information

Learn about our direct patient care programs, provided by nationally and internationally acclaimed faculty.

The goal of our interdisciplinary and interinstitutional effort is to translate science into improved clinical care.

The Department of Psychiatry provides excellence in psychiatric education throughout the entire spectrum of medical training.

News and Announcements

Collaborative Neuroscience RFA: Penn Medicine Translational Neuroscience Center
Announcement from the Co-Directors of the Penn Medicine Translational Neuroscience Center: Caryn Lerman, PhD and Frances E. Jensen, MD

To promote greater integration and translation of scientific discoveries for a high impact on patient care, the Penn Medicine Translational Neuroscience Center (PTNC) is establishing the Translational Neuroscience Initiatives (TNIs). The TNIs are designed to catalyze the formation of high-impact teams and promote greater integration between basic laboratory neuroscience, clinical research, and clinical practice. The obvious and immediate benefits of such integration include greater attention by basic neuroscientists to the most pressing clinical issues as well as the opportunity for their research hypotheses to be informed by clinician experience with treatment successes and failures. The anticipated downstream consequence is to create new scientific collaborations and consortia, thereby increasing the rate of translation of discoveries of novel molecular targets and neural systems into therapeutics that transform the care of patients with neuropsychiatric and neurological diseases.

Given the excellence of Penn neuroscience investigators and their ability to achieve important, if not dramatic, effects on patient outcomes, resources have been committed to establish at least 4 TNIs at Penn over the next 3 years. Two of these will be selected and awarded in 2016. To entice both junior and senior investigators to come together to produce highly innovative, transformational research concepts, the TNIs will be funded at a level of $400,000 direct costs over a period of 2-3 years. The focus areas, submission guidelines, and review process are described in this document. The submission deadline for the brief proposals is December 1st, 2015. Click here for the full RFA.